Quick Answer
Inspire Medical Systems, Inc. reported R&D Expense of $103.17 million for fiscal year 2025.
Inspire Medical Systems, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $103.17M | -9.6% |
| 2024 | $114.13M | -2.1% |
| 2023 | $116.54M | +69.8% |
| 2022 | $68.64M | +83.8% |
| 2021 | $37.35M | +43.1% |
| 2020 | $26.09M | +103.2% |
| 2019 | $12.84M | +73.8% |
| 2018 | $7.39M | +19.3% |
| 2017 | $6.19M | -12.6% |
| 2016 | $7.09M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $24.21M | -7.2% | -7.6% |
| June 30, 2025 | $26.21M | -9.2% | -5.7% |
| March 31, 2025 | $27.80M | -3.6% | +6.6% |
| September 30, 2024 | $26.08M | -10.5% | -9.6% |
| June 30, 2024 | $28.86M | -6.4% | +0.0% |
| March 31, 2024 | $28.85M | +13.1% | -1.0% |
| September 30, 2023 | $29.14M | +38.8% | -5.4% |
| June 30, 2023 | $30.82M | +112.1% | +20.8% |
- Inspire Medical Systems, Inc. showed a decrease of -9.6% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Inspire Medical Systems, Inc.’s r&d expense has grown by 1354.9% (from $7.09 million to $103.17 million).
- The most recent figure is from Inspire Medical Systems, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: